With the global vaccine race hotting up, and dozens of candidates being tested on humans, backers of Russia's 'Sputnik-V' shot see liability as a key battleground as they aim to capture market share
Can't let the guard down for next 2-3 months against Covid, says V K Paul of NITI Aayog; ICMR chief sas 50% vaccine efficacy acceptable in case of respiratory viruses
Business Standard brings you the top headlines of the day
The trials are part of a deal between the Russian Direct Investment Fund and Dr Reddy's.
Navalny was kept in an induced coma for more than a week while being treated with an antidote
The better view reflects the strong economic pickup in recent months and the vast injection of public resources
Moscow's COVID-19 death toll has risen by 13 over the past day to 5,057, the Russian capital's coronavirus response centre said in a statement on Saturday."Another 13 patients, who were diagnosed with pneumonia and tested positive for the coronavirus infection, died in Moscow," the centre said.On Friday, the single-day increase to the death toll was 11.
Russian Defence Minister Sergei Shoigu has said the military presence will be strengthened in the Far East in the wake of rising geopolitical tensions in the region.
The US has deployed additional troops and armored vehicles into eastern Syria after a number of clashes with Russian forces
The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia
While Dr Reddy's Labs is preparing for clinical trials of Sputnik V, major manufacturers in the country are sceptical about the drug
The comments were made on YouTube by Georgy Alburov, a member of Navalny's team
Navalny fell violently ill on a flight in Russia last month and was airlifted to Berlin for treatment
Vaccine makers here feel the Sputnik is still a work in progress and needs time to develop
OPEC and allies are scheduled to hold an online meet to discuss compliance with their agreed output cuts and demand trends amid falling oil prices and a faltering economic recovery outlook
The Russian Direct Investment Fund (RDIF), Russias sovereign wealth fund, and Dr Reddys Laboratories Ltd have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India
Business Standard brings you the top headlines of the day
The Russian Direct Investment Fund said that the deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine in India
The Russian Direct Investment Fund added that it had agreed to cooperate on clinical trials and the distribution of the vaccine with the Indian firm
Sergei Lavrov urged his Heiko Maas to abandon further politicisation of the suspected poisoning of Alexei Navalny, the Russian Foreign Ministry said after a phone conversation between the ministers